Real-time enrollment status for this macular degeneration clinical trial
Current Status
Active, Not Recruiting
Checked: July 18, 2026 at 10:25 AM UTC
| NCT Number | NCT06660667 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Macular Degeneration |
| Phase | PHASE1 |
| Target Enrollment | 66 participants |
| Active Locations | 18 sites in the US |
| Sponsor | Sanofi |
| Last Updated on CT.gov | July 16, 2026 (2 days ago) |
As of July 18, 2026: Clinical trial NCT06660667 is currently active_not_recruiting participants. This phase1 study for macular degeneration is not currently accepting new participants at 18 locations across the United States. The study is sponsored by Sanofi. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06660667 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06660667 was last updated 2 days ago (July 16, 2026). HelloStudys verifies this status automatically.